Frontlight ResearchEarly access
Trial site
Neurological Associates of Albany
- 2running trials
- 6closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease8 trials
- Mild cognitive impairment3 trials
- Phase
- Phase 34 trials
- Phase 1/21 trial
- Phase 21 trial
- Status
- Completed3 trials
- Terminated3 trials
- Active, not recruiting1 trial
- Enrolling by invitation1 trial
- Lead sponsor
- Alzheon Inc.2 trials
- Cassava Sciences, Inc.2 trials
- Cognito Therapeutics, Inc.2 trials
- Acumen Pharmaceuticals1 trial
- Vaccinex Inc.1 trial
Running trials
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease1 recruiting
- Mild cognitive impairment1 recruiting
Closed trials
Terminated
Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects
Completed
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)
Terminated
Open-label Extension for Phase 3 Clinical Trials of Simufilam
Terminated
Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease
Completed
SEMA4D Blockade Safety and Brain Metabolic Activity in Alzheimer's Disease (AD)
Completed
An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects
Site data: ClinicalTrials.govUpdated 15 Nov 2026